| Application no. and date | 11727396.1 (espacenet) (Federated) (European Patent Register), 20110601 | | Patent/reg. no. and date | DK/EP 2575784, 20180808 | | Publication date | 20130410 | | Priority no. and date | EP 10075231, 20100602, EP 11075047, 20110314 | | EP pub. no. and date |
EP 2575784 20130410 | | Effective date | | | Applicant/owner | Pharma& Schweiz GmbH, Riedstrasse 1
6330 Cham, CH | | Applicant ref. no. | 167117 | | Inventor | COLLEDGE, Jeffrey, Astellas Pharma Europe B.V.
PO Box 344
2300 AH Leiden, NL,
OLTHOFF, Margaretha, Astellas Pharma Europe BV
PO Box 344
2300 AH Leiden, NL | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 47/10 (2017.01) , A61K 9/14 (2006.01) , A61K 9/48 (2006.01) | | Title | ORALE DOSERINGSFORMER AF BENDAMUSTIN | | Int. application no. | EP2011002764 | | Int. publication no. | WO2011151087 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
